Epstein-Barr virus nuclear antigen 3C interact with p73: Interplay between a viral oncoprotein and cellular tumor suppressor (Q39046899)

8 September 2017

title

Epstein-Barr virus nuclear antigen 3C interact with p73: Interplay between a viral oncoprotein and cellular tumor suppressor (English)

1 reference

8 September 2017

0 references

1 reference

9 November 2018

Sushil Kumar Sahu

1 reference

8 September 2017

Suchitra Mohanty

1 reference

8 September 2017

Amit Kumar

1 reference

8 September 2017

Chanakya N Kundu

1 reference

8 September 2017

Tathagata Choudhuri

1 reference

8 September 2017

language of work or name

English

0 references

publication date

12 November 2013

1 reference

8 September 2017

1 reference

8 September 2017

volume

448

1 reference

8 September 2017

page(s)

333-343

1 reference

p53 mutation and expression in lymphoma

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Regulating the genome surveillance system: miRNAs and the p53 super family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Some p53-binding proteins that can function as arbiters of life and death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Multiple isoforms of the tumor protein p73 are expressed in the adult human telencephalon and choroid plexus and present in the cerebrospinal fluid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

p73 is transcriptionally regulated by DNA damage, p53, and p73

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Expression of alpha V integrin is modulated by Epstein-Barr virus nuclear antigen 3C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Oncogene AF1q enhances doxorubicin-induced apoptosis through BAD-mediated mitochondrial apoptotic pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Measles virus V protein inhibits p53 family member p73

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

p63 and p73 in human cancer: defining the network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

The role of p53 in chemosensitivity and radiosensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Doxorubicin in lymphoma: association between pharmacokinetic variability and clinical response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Importance of non-selective cation channel TRPV4 interaction with cytoskeleton and their reciprocal regulations in cultured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Early events associated with infection of Epstein-Barr virus infection of primary B-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Role for the p53 homologue p73 in E2F-1-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

p73 is a simian [correction of human] p53-related protein that can induce apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Triggering of p73-dependent apoptosis in osteosarcoma is under the control of E2Fs-pRb2/p130 complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Epstein-Barr Virus (EBV): infection, propagation, quantitation, and storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

P53 mutations in lymphomas: position matters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

p73: a chiaroscuro gene in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Viral oncoproteins discriminate between p53 and the p53 homolog p73.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Evidence that p53-mediated cell-cycle-arrest inhibits chemotherapeutic treatment of ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Innate immune modulation in EBV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

The p53 family and programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

p73 induces apoptosis by different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

The jury is in: p73 is a tumor suppressor after all.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

p73-dependent apoptosis through death receptor: impairment by human cytomegalovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Epstein-Barr virus and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Enhanced p73 expression during differentiation and complex p73 isoforms in myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

New p73 variants with altered C-terminal structures have varied transcriptional activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

p73 or p53 directly regulates human p53 transcription to maintain cell cycle checkpoints.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.10.023

10.1016/J.VIROL.2013.10.023

7 January 2021

Identifiers

DOI

1 reference

release_d27pjkowrzaere6tulk6e6v3pa

8 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d27pjkowrzaere6tulk6e6v3pa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference